TwoStep Therapeutics

<span>TwoStep Therapeutics</span> <span><span>riverh29</span></span> <span><time datetime="2026-09-14T09:01:46-04:00" title="Monday, September 14, 2026 - 09:01">Mon, 09/14/2026 - 09:01</time> </span> <a href="https://www.pfizer.com/taxonomy/term/11726" hreflang="en">Active Portfolio Companies</a> <p>TwoStep Therapeutics is a biotechnology company developing a pipeline built around a versatile targeting peptide that selectively binds multiple tumor-associated integrins—a unique feature that enables the delivery of diverse payloads across a wide range of solid tumor types. The company leverages this technology to develop targeted cancer therapies for cytotoxic drug delivery and radioligand therapy.</p> <img loading="lazy" src="https://cdn.pfizer.com/pfizercom/TwoStep_logo.png?VersionId=0eOdclYggnxSAHwQvo.MDutaAYsCytR3" width="1363" height="562" alt="TwoStep Logo"> San Carlos, California <a href="https://twosteptx.com/">https://twosteptx.com/</a> — Company newsroom — sourced from Pfizer. Matter furnished by the company. Not a Notice Nearby paid placement. This page reprints matter furnished by the company from its official newsroom. Notice Nearby did not write this release. Read the original: https://www.pfizer.com/node/563618